4//SEC Filing
DiLucente Anthony 4
Accession 0001104659-21-026194
CIK 0001428875other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:30 PM ET
Size
23.0 KB
Accession
0001104659-21-026194
Insider Transaction Report
Form 4
DiLucente Anthony
Sr. Vice President & CFO
Transactions
- Sale
Common Stock
2021-02-18$50.24/sh−16,951$851,561→ 27,775 total - Exercise/Conversion
Restricted Stock Units
2021-02-18−1,507→ 1,507 total→ Common Stock (1,507 underlying) - Exercise/Conversion
Employee Stock Options (Right to buy)
2021-02-18−9,352→ 9,352 totalExercise: $37.07Exp: 2028-02-18→ Common Stock (9,352 underlying) - Exercise/Conversion
Common Stock
2021-02-18+7,599→ 35,374 total - Exercise/Conversion
Common Stock
2021-02-18+1,507→ 27,775 total - Exercise/Conversion
Common Stock
2021-02-18+9,352→ 44,726 total - Tax Payment
Common Stock
2021-02-19$49.45/sh−2,312$114,318→ 25,463 total - Exercise/Conversion
Common Stock
2021-02-18+4,047→ 26,268 total - Exercise/Conversion
Restricted Stock Units
2021-02-18−4,047→ 0 total→ Common Stock (4,047 underlying) - Exercise/Conversion
Employee Stock Options (Right to buy)
2021-02-18−7,599→ 7,598 totalExercise: $40.04Exp: 2027-02-18→ Common Stock (7,599 underlying)
Footnotes (8)
- [F1]Each unit is the economic equivalent of one share of the Company's common stock. The restricted stock units were granted on February 18, 2018, and vest and settle in three equal installments on the first three anniversaries of the grant date.
- [F2]Each unit is the economic equivalent of one share of the Company's common stock. The restricted stock units were granted on February 18, 2019, and vest and settle in three equal installments on the first three anniversaries of the grant date, subject to continued employment with the Company.
- [F3]These stock options were granted on February 18, 2019, and vest and become exercisable in three equal annual installments on the first anniversary of the grant date, subject to continued employment with the Company.
- [F4]These stock options were granted on February 18, 2018, and vest and become exercisable in four equal annual installments on the first anniversary of the grant date, subject to continued employment with the Company.
- [F5]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F6]The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.93 - $50.81, inclusive. The reporting person undertakes to provide Terminix, any security holder of Terminix, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- [F7]The reporting person is reporting the sale of shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting and delivery of shares.
- [F8]The price reported in Table 1, Column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.31 - $49.5150, inclusive. The reporting person undertakes to provide Terminix, any security holder of Terminix, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Documents
Issuer
TERMINIX GLOBAL HOLDINGS INC
CIK 0001428875
Entity typeother
Related Parties
1- filerCIK 0001695629
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:30 PM ET
- Size
- 23.0 KB